Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
University of Pennsylvania Inc
Search grants from University of Pennsylvania Inc
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
University of Medicine & Dentistry of NJ
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mechanisms of Homeodomain Transcriptional Specificity
AgRP neurons regulate bone remodeling in aging
Bacterial influences on synapse formation
Residency Training in Gim and/OR Gp
2012 Plant Molecular Biology Gordon Research Conference, Holderness School, New Hampshire, July 15-20, 2012
Recently added grants:
Administrative Core
Project 1 - Development of mRNA Immunogens for Protective Antibody Induction
Project 2 - GMP Manufacturing of mRNA Immunogens
Mechanisms of MHCII expression and CD4+ T cell activation during Chlamydia trachomatis infection
In Vivo Gene Editing for HIV-1 Cure
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025118-000
Application #
6688659
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
University of Pennsylvania Inc
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
/ University of Pennsylvania Inc
NIH 2002
N01 CA
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
/ University of Pennsylvania Inc
Comments
Be the first to comment on this grant